by STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Language
🇺🇲
Publishing Since
3/2/2018
Email Addresses
1 available
Phone Numbers
0 available
April 10, 2025
Host John Carroll interviews John Crowley, CEO of BIO, about the impact of tariffs and the need for increased federal biotech funding.
April 3, 2025
STAT reporter Lizzy Lawrence interviews industry experts about recent FDA leadership changes and AstraZeneca's new cholesterol-lowering drug.
March 27, 2025
Hosts Adam Fein, Elaine Quilici, and Allison B. Cohen explore recent healthcare policy changes and discuss AI advancements in cancer treatment with Altis Labs CEO
Matt Pillar
BioCentury
Andreessen Horowitz, a16z Bio + Health
Timmerman Report
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more
Biotech 2050
Eric Topol
Andreessen Horowitz
Ben Gilbert and David Rosenthal
Sequoia Capital
Marketplace
Colossus | Investing & Business Podcasts
Tradeoffs
Bloomberg
NEJM Group
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.